National Cancer InstituteU.S. National Institutes of
Center to Reduce Cancer Health Disparities, Patient Navigation Program (PNP) logo

Project Investigator Biography

Steven R. Patierno, Ph.D. Steven R. Patierno, Ph.D.

The George Washington University, Cancer Institute
Ross Hall, Room 514
2300 Eye Street, NW
Washington, DC 20037
phone: (202) 994-2449
fax: (202) 994-1714

Dr. Steven R. Patierno is Executive Director of the George Washington University Cancer Institute (GWCI); Director of the Molecular and Cellular Oncology Program, Professor of Pharmacology; Genetics and Urology in the School of Medicine and Health Science; and Professor of Environmental and Occupational Health in the School of Public Health and Health Services.

Dr. Patierno's research laboratory, which focuses on lung, prostate, breast, and skin cancers, has made major contributions to our understanding of the role genetic damage in the balance of cell death and survival. He is internationally recognized as a leading expert in cancer causation and carcinogenesis. In addition, his laboratory has explored the mechanisms of development of cancer cell resistance to chemotherapy and the development of bio-therapeutics that control the metastatic spread of cancer. Dr. Patierno's laboratory discovered the anti-cancer activity of a protein that is the subject of 11 U.S. patents and is currently under commercial development by a bio-pharmaceutical company as a molecularly targeted cancer therapeutic. In 1999, Dr. Patierno received the GW Distinguished Researcher Award.

He earned his doctoral degree at the Graduate School of Biomedical Science, University of Texas Health Science Center in Houston. At the MD Anderson Cancer Institute, where he worked on the genetics of cancer causation he was awarded the prestigious Rosalie B. Hite Graduate Fellowship in Cancer Research.

Dr. Patierno has authored over 100 scientific journal articles and book chapters. He is an accomplished teacher and mentor to many graduate students, postdoctoral fellows, and medical residents and was the founding Director of the GW Molecular and Cellular Oncology Ph.D. Program. He serves on the editorial boards of a number of scientific journals, has chaired many review panels for the National Institutes of Health and other government agencies, and is a member of the Scientific Advisory Board of several bio-pharmaceutical companies.

For his citywide leadership in the area of cancer disparities, Dr. Patierno recently received a Distinguished Public Service Award by the Breast Cancer Resource Committee, a Washington-based advocacy organization focused on cancer care among African Americans.

View Project Description
Updated: 07/23/09